Successfully merged with Humacyte, Inc. • Now trading as HUMA
SPAC Overview
$100M
IPO Size
$100M
Trust (as of 2021-06-30)
Completed
Current Status
2020
IPO Year
Timeline Progress
About
A newly organized blank-check company seeking an initial business combination with an unidentified business, with its search focused on healthcare companies in the United States.
Investment Focus
Healthcare
Geographic Focus
United States
The terms and the filing trail behind Alpha Healthcare Acquisition Corp.
What the sponsor registered, what the deal actually priced at, and every 8-K that moved it — unit structure, sponsor promote, and the dated lifecycle events, each linked to its filing.
- Unit structure as registered and as priced — price, warrant coverage, rights, trust per unit
- Sponsor promote: founder shares and percentage, private-placement warrants, trust deposit
- The full 8-K lifecycle timeline, each event linked to its filing
- Price history across the unit, share and warrant tickers
- Follow it, and see it change on your watchlist
SPAC Team
Sponsors
Leadership
Kathleen Sebelius
Chair of the Board of Directors
Rajiv S. Shukla
Chairman of the Board of Directors, Chief Executive Officer, Director
Laura E. Niklason
Chief Executive Officer, Director, President, President and Chief Executive Officer
Dale A. Sander
Chief Corporate Development Officer, Chief Financial Officer, Treasurer
Douglas L. Blankenship
Former Chief Financial Officer and Treasurer
Patrick Alexander Sturgeon
Chief Financial Officer, Secretary
Heather Ledbetter Prichard
Chief Operating Officer
Jeffrey Harold Lawson
Chief Surgical Officer, Director
Kiernan Thomas Deangelis
Chief Medical Officer
William John Scheessele
Chief Commercial Officer
William Tente M.S.
Chief Regulatory Officer
Brady W. Dougan
Director
Brian Clanton Robertson
Director
Bruce A. Springer
Director
Emery N. Brown
Director
Gordon M. Binder
Director
Kevin Xie
Director
Max N. Wallace
Director
Michael T. Constantino
Director
Susan Richards Windham-Bannister
Director
Terrance L. Carlson
Director
Todd M. Pope
Director
Gavril Abramovich Yushvaev
William Edward Tente
Extended Team Information
Led by Rajiv Shukla, with healthcare investment, operating, and SPAC experience, and Patrick A. Sturgeon, with M&A, capital markets, and SPAC experience; director nominees bring healthcare, technology, and business expertise.
Stock Performance
HUMA
Trading Symbol
First Trade
December 1, 2020
$9.70
At Merger
August 27, 2021
$12.20
+26%
6 Months Post-Merger
March 1, 2022
$5.89
-52%
1 Year Post-Merger
August 31, 2022
$3.65
-70%
2 Years Post-Merger
August 28, 2023
$3.78
-69%
Current Price
October 1, 2026
$0.50
-95%
Key Information
IPO Date
September 18, 2020
Total Redemptions
$30.1M
PIPE
$175M
State of Incorporation
DE
SIC
6770
Completion Date
August 26, 2021
Merger Target
Humacyte, Inc.
SPAC Ticker
AHAC
Merged Ticker
HUMA